前收市價 | 88.61 |
開市 | 88.00 |
買盤 | 88.24 x 800 |
賣出價 | 87.75 x 800 |
今日波幅 | 86.66 - 88.73 |
52 週波幅 | 60.57 - 96.12 |
成交量 | |
平均成交量 | 4,007,522 |
市值 | 53.337B |
Beta 值 (5 年,每月) | 1.07 |
市盈率 (最近 12 個月) | 38.43 |
每股盈利 (最近 12 個月) | 2.29 |
業績公佈日 | 2024年7月24日 - 2024年7月29日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 94.52 |
Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.13% and 1.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences stock was muted late Thursday after the company beat first-quarter calls and gave more color into a looming spinoff.